英文别名 |
CH5183284;CH5183284 (Debio-1347);Debio 1347;DEBIO-1347;CH-5183284;FF284;NR9ZYH80Z8;(5-Amino-1-(2-methyl-1H-benzo[d]imidazol-6-yl)-1H-pyrazol-4-yl)(1H-indol-2-yl)methanone;[5-Amino-1-(2-Methyl-1h-Benzimidazol-6-Yl)-1h-Pyrazol-4-Yl](1h-Indol-2-Yl)methanone;BEMNJULZEQTDJY-UHFFFAOYSA-N;DEBIO1347;GTPL9787;BCP14354;BDBM50197683;s7665;DB12903;CS-5;Zoligratinib;HMS3748K13;NSC-782363;Q27285013;MFCD28502053;ZOLIGRATINIB [WHO-DD];1265229-25-1;Fgfr inhibitor debio 1347;NSC800074;(5-AMINO-1-(2-METHYL-3H-BENZIMIDAZOL-5-YL)PYRAZOL-4-YL)-(1H-INDOL-2-YL)METHANONE;BRD-K11683436-001-02-5;CS-5504;HY-19957;4-(1H-indole-2-carbonyl)-2-(2-methyl-1H-1,3-benzodiazol-5-yl)pyrazol-3-amine;AKOS027427006;(5-AMINO-1-(2-METHYL-1H-BENZIMIDAZOL-6-YL)-1H-PYRAZOL-4-YL)-1H-INDOL-2-YLMETHANONE;BRD-K11683436-001-01-7;SB16908;Debio-1347;UNII-NR9ZYH80Z8;NSC782363;[5-amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazol-4-yl]-(1H-indol-2-yl)methanone;Methanone, (5-amino-1-(2-methyl-1H-benzimidazol-6-yl)-1H-pyrazol-4-yl)-1H-indol-2-yl-;BS-14797;debio 1347-101;NS00073159;4-(1h-indole-2-carbonyl)-1-(2-methyl-1h-1,3-benzodiazol-6-yl)-1h-pyrazol-5-amine;zoligratinib;EX-A1122;NCGC00386433-01;CH5183284; Debio-1347;AC-32960;ZOLIGRATINIB [INN];SCHEMBL10002991;CH5183284 (Debio-1347)?;[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone;HMS3674G21;[5-Amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazol-4-yl]-(1H-indol-2-yl)-methanone;NSC-800074;LWJ;(5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl)-(1H-indol-2-yl)methanon;Debiopharm 1347;CH 5183284;CCG-264725;[5-amino-1-(2-methyl-3h-benzimidazol-5-yl)pyrazol-4-yl](1h-indol-2-yl)methanone;CHEMBL3907479;[5-amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazol-4-yl]-(1H-indol-2-yl) methanone |